
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Bacillus coagulans GBI-30 6086 is a spore-forming probiotic strain that produces lactic acid and antimicrobial compounds to support digestive health. This soil-based probiotic survives stomach acid and colonizes the intestinal tract, promoting beneficial bacteria growth and reducing inflammatory cytokines.

Reported Benefits (Provisional)
Origin & History

Bacillus coagulans GBI-30 6086 is a soil-based probiotic strain derived from natural soil environments. It is produced through fermentation and is known for its ability to survive in harsh conditions.
Research Narrative (Provisional)
Clinical trials have demonstrated its efficacy in supporting digestive health and reducing IBS symptoms. Studies highlight its stability and resilience.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Produces lactic acid, aiding in gut health. - Contains spores that ensure survival through the digestive tract. - Supports the production of beneficial short-chain fatty acids.
Reported Mechanism (Provisional)
Bacillus coagulans GBI-30 6086 produces lactic acid through lactate dehydrogenase, lowering intestinal pH to inhibit pathogenic bacteria growth. The strain synthesizes antimicrobial bacteriocins and modulates immune responses by reducing pro-inflammatory cytokines IL-6 and TNF-alpha while increasing immunoglobulin A production. Its spore-forming capability allows survival through gastric acid, enabling colonization in the small and large intestines.
Clinical Narrative (Provisional)
Multiple randomized controlled trials with 50-300 participants demonstrate efficacy for digestive health and immune support. Studies show 2 billion CFU daily reduces IBS symptoms by 20-40% and decreases upper respiratory infections by 27%. A 90-day trial found significant improvements in protein absorption and reduced inflammatory markers. However, most studies are relatively small and short-term, requiring larger long-term trials for definitive conclusions.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







